Evans DGR - Search Results

1

BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?

Morgan RD, Burghel GJ, Flaum N, Bulman M, Smith P, Clamp AR, Hasan J, Mitchell CL, Salih Z, Woodward ER, Lalloo F, Crosbie EJ, Edmondson RJ, Wallace AJ, Jayson GC, Evans DGR. Morgan RD, et al. Among authors: evans dgr. Br J Cancer. 2022 Jul;127(1):163-167. doi: 10.1038/s41416-022-01773-y. Epub 2022 Mar 8. Br J Cancer. 2022. PMID: 35260807 Free PMC article. Review.

2

Uptake of screening and prevention in women at very high risk of breast cancer.

Evans D, Lalloo F, Shenton A, Boggis C, Howell A. Evans D, et al. Lancet. 2001 Sep 15;358(9285):889-90. doi: 10.1016/S0140-6736(01)06039-1. Lancet. 2001. PMID: 11567707

3

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.

Lalloo F, Varley J, Ellis D, Moran A, O'Dair L, Pharoah P, Evans DG; Early Onset Breast Cancer Study Group. Lalloo F, et al. Lancet. 2003 Mar 29;361(9363):1101-2. doi: 10.1016/S0140-6736(03)12856-5. Lancet. 2003. PMID: 12672316

4

Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.

Astuti D, Hart-Holden N, Latif F, Lalloo F, Black GC, Lim C, Moran A, Grossman AB, Hodgson SV, Freemont A, Ramsden R, Eng C, Evans DG, Maher ER. Astuti D, et al. Clin Endocrinol (Oxf). 2003 Dec;59(6):728-33. doi: 10.1046/j.1365-2265.2003.01914.x. Clin Endocrinol (Oxf). 2003. PMID: 14974914

5

Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.

Baser ME, Kuramoto L, Joe H, Friedman JM, Wallace AJ, Gillespie JE, Ramsden RT, Evans DG. Baser ME, et al. Am J Hum Genet. 2004 Aug;75(2):231-9. doi: 10.1086/422700. Epub 2004 Jun 9. Am J Hum Genet. 2004. PMID: 15190457 Free PMC article.

6

Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.

Stirling D, Evans DG, Pichert G, Shenton A, Kirk EN, Rimmer S, Steel CM, Lawson S, Busby-Earle RM, Walker J, Lalloo FI, Eccles DM, Lucassen AM, Porteous ME. Stirling D, et al. J Clin Oncol. 2005 Aug 20;23(24):5588-96. doi: 10.1200/JCO.2005.05.097. J Clin Oncol. 2005. PMID: 16110018

7

BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.

Lalloo F, Varley J, Moran A, Ellis D, O'dair L, Pharoah P, Antoniou A, Hartley R, Shenton A, Seal S, Bulman B, Howell A, Evans DG. Lalloo F, et al. Eur J Cancer. 2006 May;42(8):1143-50. doi: 10.1016/j.ejca.2005.11.032. Epub 2006 Apr 27. Eur J Cancer. 2006. PMID: 16644204

8

Optimal selection of individuals for BRCA mutation testing.

Evans DG, Lalloo F, Eccles D. Evans DG, et al. J Clin Oncol. 2006 Jul 10;24(20):3311; author reply 3311-2. doi: 10.1200/JCO.2006.06.6134. J Clin Oncol. 2006. PMID: 16829657 No abstract available.

9

Breast cancer risk-assessment models.

Evans DG, Howell A. Evans DG, et al. Breast Cancer Res. 2007;9(5):213. doi: 10.1186/bcr1750. Breast Cancer Res. 2007. PMID: 17888188 Free PMC article. Review.

10

What are the implications in individuals with unilateral vestibular schwannoma and other neurogenic tumors?

Evans DG, Ramsden RT, Shenton A, Gokhale C, Bowers N, Huson SM, Wallace AJ. Evans DG, et al. J Neurosurg. 2008 Jan;108(1):92-6. doi: 10.3171/JNS/2008/108/01/0092. J Neurosurg. 2008. PMID: 18173316

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page